# Nuvalent (NUVL) 股價因 GSK 同意以 106 億美元收購 Nuvalent 而上漲。

*biotech, business · news · 2026-06-09 · MarketScreener*

## Key points

- GSK 以 106 億美元收購 Nuvalent，擴大其肺癌治療產品組合。
- Nuvalent 股價在與 GSK 達成收購協議後上漲。
- JM Smucker 第四季利潤因產品價格上漲超出華爾街預期。
- Vail Resorts 因美國西部天氣嚴峻，下調全年淨利指引。

On this episode of Stock Movers with Alexis Christoforous: - Nuvalent (NUVL) shares are higher on news GSK agreed to buy Nuvalent for $10.6 billion, securing a US biotech firm developing treatments for lung cancer. - JM Smucker (SJM) shares are on the move after it posted fourth-quarter profits that beat Wall Street expectations as higher prices helped boost the packaged food company. - Vail Resorts (MTN) is dropping after the ski resort operator cut its net income guidance for the full year, attributing the reduction to "historically challenging" weather conditions in the western US. The guidance missed the average analyst estimate. Bloomberg videos, provided by MT Newswires

**Companies:** GSK, Nuvalent, JM Smucker, Vail Resorts
**Countries:** United States, United Kingdom

[Read the full story on MarketScreener](https://www.marketscreener.com/news/jm-smucker-moves-on-profit-beat-vail-resorts-down-on-full-year-guidance-cut-stock-movers-ce7f5cdad880f526)

---

Canonical: https://newsio.io/zh-TW/n/2465056d-87e2-4f21-9cd3-0c8fa546e96a/nuvalent-nuvl-gsk-106-nuvalent-vail-resorts-mtn
Summarized by Newsio from MarketScreener. https://newsio.io/how-it-works